Spirodin-M 10 Tablets

babies: not applicable. lactation mother: doxofylline and montelukast sodium tablets is safe if prescribed by a doctor in lactating mothers.
studies suggest that this medication may cause toxicity to the baby. pregnancy: consult your doctor before using this medication.
driving: this medication may affect your ability to drive. do not drive if you feel dizzy.
alcohol: doxofylline, montelukast sodium tablet is used with caution with alcohol as it may increase your drowsiness kidney: this medication should be used with caution in patients with kidney disease. consult your doctor before using this medication.
liver: this medication should be used with caution in patients with liver disease. you may need a dose adjustment..

Nausea Vomiting Stomach pain Epigastric pain Headache Insomnia (difficulty in sleeping) Irritation Increased heart rate Flu-like symptoms.

SPIRODIN M tablets are used to treat asthma by promoting smooth muscle relaxation in the airways and widens the airway. and by blocking the action of chemical messenger that is responsible for causing inflammation in the airways respectively..

If you miss a dose of SPIRODIN M, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• SPIRODIN M tablets are prescribed to treat asthma. • take this mediation as prescribed by your doctor.
please do not exceed the dose as it may lead to cause side effects and toxicity. • do not use it to relieve sudden breathing problems.
use your rescue inhaler to control sudden difficulty in breathing. • doxofylline, montelukast tablet may cause side effects such as nausea, vomiting, stomach pain, epigastric pain, headache, insomnia, irritation, increased heart rate and flu-like symptoms.
inform your doctor if these conditions bother you or persist for a long time. • inform your doctor if you smoke or have a viral infection.
• this medication is taken evening after food..

• montelukast sodium + dasabuvir: concurrent use of these drugs results in increased dasabuvir concentration. • montelukast sodium + leflunomide/trimethoprim/pixantrone: concurrent use of these drugs results in increased exposure of cyp2c8 substrate.
• montelukast sodium + gemfibrozil: concurrent use of these drugs results in elevated montelukast plasma concentration. • montelukast sodium + phenobarbital/rifampicin: concurrent use of these drugs decreases montelukast's bioavailability.
• montelukast sodium + prednisone: concurrent use of these drugs results in severe peripheral oedema..